Protalix BioTherapeutics, Inc. Logo Image

Protalix BioTherapeutics, Inc.

Most Recent Annual Report

2019 Annual Report and Form 10K

Protalix BioTherapeutics, Inc.

Protalix BioTherapeutics, Inc. does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Archived Annual Reports

About Protalix BioTherapeutics, Inc.

201-500 Employees
Based in Karmiel, Israel

Protalix BioTherapeutics, Inc., a biopharmaceutical company, through Protalix Ltd., focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system in the United States.

Ticker:
PLX
Exchange:
AMEX (See More AMEX Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol

Filter by: